Peptides · Evidence-graded entry

Biotinoyl tripeptide-1 and Procapil claims: what the evidence shows

Name: Biotinoyl tripeptide-1 and Procapil claims: what the evidence shows
Creator: SoftMaxx AI Editorial
Published: 2026-09-30

Biotinoyl tripeptide-1, evidence-graded: we found no trial of it; small studies test Procapil, a blend containing it as sellers describe it.

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed · How we grade evidence

SoftMaxx AI sells no peptides and takes no vendor money.

The verdict · strongest evidence No supporting study

No supporting study We found no trial of biotinoyl tripeptide-1. The human studies we found test Procapil, a blend that includes biotinoyl tripeptide-1 as sellers describe it (none of the studies' abstracts lists its contents), together with platelet-rich plasma (PRP) or caffeine. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better than PRP alone after 6 months; in a 54-man randomized trial, Procapil with PRP did worse than redensyl, saw palmetto and biotin with PRP.^[1][2][3]

The tier describes the evidence for biotinoyl tripeptide-1 itself; the human studies on this page test Procapil, a blend that includes it as sellers describe it.

What Biotinoyl tripeptide-1 is

The EU cosmetic-ingredient database (CosIng) lists biotinoyl tripeptide-1 as 'the reaction product of Biotin and Tripeptide-1', with the function 'hair conditioning' (CosIng entry). A 2025 review lists Procapil among the most hyped topical hair actives ^[4]; none of the abstracts we read lists Procapil's ingredients.

Expert review We found no peer-reviewed test of the mechanisms marketed for it. A 2025 review of the most hyped topical hair actives, Procapil among them, found the studies mostly small, tested in multi-ingredient formulas, rarely compared with standard therapies, and often with conflicts of interest ^[4]. A 2026 review describes short peptides as a promising approach for hair loss that has limitations ^[5].^[4][5]

Claims vs. evidence

Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.

Claim as marketedReduces hair loss / improves androgenetic alopeciaHuman, small or uncontrolled (Procapil data) The studies we found test Procapil together with PRP or caffeine; we found no study of biotinoyl tripeptide-1 itself, an ingredient of Procapil as sellers describe it, and none of the abstracts we read describes a placebo arm. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better on dermatologist and patient ratings than PRP alone at 6 months; in a 54-man randomized trial, the comparison group (redensyl, saw palmetto and biotin, with PRP) did better than Procapil with PRP; a short report tested caffeine with Procapil.^[2][1][3][4]
Claim as marketedAnchors hair / strengthens follicleNo supporting study We found no peer-reviewed study testing this claim. A 2025 review of topical hair actives, Procapil among them, notes small studies, multi-ingredient formulas and conflicts of interest.^[4]
Claim as marketedWorks as well as minoxidilNo supporting study We found no head-to-head trial against minoxidil or finasteride. In a meta-analysis of randomized trials, minoxidil (in men and in women) and 1 mg finasteride (in men) beat placebo.^[6][7]

Common myths, checked

Common beliefProcapil is a clinically proven natural alternative to minoxidil or finasteride.Human RCT (Procapil data) We found no head-to-head trial against minoxidil or finasteride. The human studies we found test Procapil alongside PRP or caffeine, and in the one randomized trial we found, Procapil with PRP did worse than the comparison arm. A 2025 review notes small samples and little comparison with standard therapies.^{[2][1][4][6][3]}
Common beliefProcapil blocks DHT.No supporting study The abstracts of the human Procapil studies report hair ratings and photographs, not DHT or other hormones, and we found no study of Procapil or biotinoyl tripeptide-1 that measured DHT.^[1][2]
Common beliefThe biotin in it feeds your hair.No supporting study CosIng lists biotinoyl tripeptide-1 as the reaction product of biotin and tripeptide-1 (CosIng entry). We found no study showing that this delivers a biotin effect to hair follicles.^[5]

Doses used in studies (not a recommendation)

These are the amounts given to the people, animals or cells in the cited studies, copied as reported. They are a record of what was tested, not dosing instructions, and nothing here says what you should take.

Studied in	Route	Amount reported	How often	How long	n	Source
Humans	topical Procapil 5% solution + 4 PRP sessions	5% Procapil	twice daily topical; PRP every 4 weeks	6 months	160	^[1] 160 patients with androgenetic alopecia (quasi-experimental, 80 per arm)
Humans	topical Procapil + PRP	Procapil concentration not stated in abstract	PRP every 3 weeks (4 sessions); Procapil schedule not stated in abstract	4 PRP sessions at 3-week intervals (total length not stated in abstract)	54	^[2] 54 men with androgenetic alopecia (RCT, 27 per arm)
Humans	topical caffeine + Procapil 3%	3% Procapil	not characterised (short report without abstract)	not characterised	—	^[3] men with pattern hair loss

Side effects and risks

Expert review A 2025 review describes these topical hair actives as having a less significant side-effect profile; we found no long-term safety study^[4]

Regulatory status (checked 2026-09-30)

United States (FDA)We found no FDA-approved product containing biotinoyl tripeptide-1 in Drugs@FDA (searched 2026-10-01). (FDA: Drugs@FDA search: biotinoyl-tripeptide-1 — no approved product found) FDA does not approve cosmetic products or ingredients (other than color additives) before they go on the market, and a product intended to affect the structure or any function of the body is legally a drug. (FDA: Is It a Cosmetic, a Drug, or Both?)
CanadaWe found no product containing biotinoyl tripeptide-1 in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada: Health Canada Drug Product Database search: biotinoyl-tripeptide-1 — no product found)
Sport (WADA)WADA’s Prohibited List does not name biotinoyl tripeptide-1. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether biotinoyl tripeptide-1 is one of them. (WADA: World Anti-Doping Code International Standard Prohibited List 2026; WADA: World Anti-Doping Agency Prohibited List)

Official sources: FDA: Is It a Cosmetic, a Drug, or Both? · WADA: World Anti-Doping Code International Standard Prohibited List 2026 · WADA: World Anti-Doping Agency Prohibited List

Report a side effect

If something went wrong after using any product, tell a clinician and report it. Reports are how regulators find contaminated or mislabeled products.

FDA MedWatch (United States)
Canada Vigilance Program (Canada)

Common questions

Does procapil block DHT?

No supporting study The abstracts of the human Procapil studies report hair ratings and photographs, not DHT or other hormones, and we found no study of Procapil or biotinoyl tripeptide-1 that measured DHT.^[1][2]

Procapil vs minoxidil?

No supporting study We found no head-to-head trial against minoxidil or finasteride. In a meta-analysis of randomized trials, minoxidil (in men and in women) and 1 mg finasteride (in men) beat placebo.^[6][7]

Does procapil work?

Human, small or uncontrolled We found no trial of biotinoyl tripeptide-1. The human studies we found test Procapil, a blend that includes biotinoyl tripeptide-1 as sellers describe it (none of the studies' abstracts lists its contents), together with platelet-rich plasma (PRP) or caffeine. In a 160-person non-randomized trial, PRP with a Procapil solution (strength in the doses table) scored better than PRP alone after 6 months; in a 54-man randomized trial, Procapil with PRP did worse than redensyl, saw palmetto and biotin with PRP.^[1][2][3]

References

Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.

COMPARISON OF PLATELET RICH THERAPY ALONE WITH PLATELET RICH THERAPY ALONG WITH DAILY TOPICAL 5% PROCAPIL APPLICATION FOR THE TREATMENT OF ANDROGENETIC ALOPECIA. J Ayub Med Coll Abbottabad (2024). PubMed 39609969 DOI
A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia. Cureus (2023). PubMed 37292551 DOI
Assessment of the efficacy and tolerability of a topical formulation containing caffeine and Procapil 3% for improvement of male pattern hair loss. J Cosmet Dermatol (2024). PubMed 37990760 DOI
Topical Alternatives for Hair Loss: Beyond the Conventional. Int J Trichology (2025). PubMed 40654553 DOI
Overview of Short Peptides for Hair Loss. Biomedicines (2026). PubMed 42072405 DOI
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol (2017). PubMed 28396101 DOI
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatol (2022). PubMed 35107565 DOI

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed. Editorial standards · Evidence grading and update log.